-
The company agreed to make the payments to resolve federal criminal and civil investigations of its marketing practices. Five of its executives were convicted separately for the same practices.
-
Last fall, Merck said it would stop selling its rotavirus vaccine to West Africa and redirect its supply to China at a higher price. After NPR broke the story, the situation changed — for the good.
-
The federal government accused John Kapoor, the founder of Insys Therapeutics, and his co-defendants of running a nationwide bribery scheme that contributed to the opioid crisis.
-
According to a new NPR/Ipsos opioid poll, 71% of Americans surveyed also say the government should do more to curb the epidemic.
-
The Senate Finance Committee will hear Tuesday from executives from the biggest pharmacy benefit managers. Confidential rebates paid to the PBMs are expected to draw scrutiny.
-
Attorney General Mike Hunter said paring back the suit against companies at the center of the national epidemic will speed up any payouts and help communities recover.
-
Federal prosecutors say the pharmaceutical company paid off doctors and manipulated insurance companies to increase the number of patients taking its opioid Subsys.
-
The state's attorney general is targeting one of America's richest families. A lawsuit filed Thursday claims the Sackler family, owners of Purdue Pharma, profited illegally in Oxycontin sales.
-
The maker of OxyContin will pay to settle a historic opioid lawsuit brought by the attorney general of Oklahoma. Will other drugmakers named in the lawsuit follow?
-
The Trump administration wants to increase transparency in prescription drug pricing. But health economists say the administration's call to tie prices to what other nations pay might work better.